BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 26, 2013
View Archived Issues
D-Pharm begins phase II study of DP-b99 in high-risk pancreatitis
Read More
Regulus Therapeutics provides update on biomarker collaboration with Biogen Idec
Read More
New test for predicting response to cancer therapy launched by Serametrix
Read More
Trial shows promising results for SAPPHIRE II eye test designed to identify AD
Read More
Lpath focuses on new antibody program targeting respiratory disease
Read More
PF-06463922, a novel small molecule for the treatment of cancer
Read More
Taiho presents data on two SYK inhibitors for DLBCL
Read More
Demonstration of the antitumor efficacy of a novel kinase inhibitor for breast and prostate cancer
Read More
Novel apoptotic agent induces cell death in lung tumors
Read More
First-in-human results support proof of mechanism for MAO-B inhibition by YKP-10461
Read More
Eisai to receive marketing authorization holder license for Gliadel in Japan
Read More
CCX-650 leads to significantly prolonged survival in animal models of glioblastoma
Read More
GlaxoSmithKline patents new MCH1 receptor antagonists
Read More
Novel PKC-beta inhibitors synthesized at Sanofi
Read More
Bayer Schering Pharma designs new BUB1 inhibitors
Read More
Ariad Pharmaceuticals obtains positive CHMP opinion on the continued use of Iclusig
Read More
TG Therapeutics begins first combination trial of TG-1101 and TGR-1202
Read More
Andexanet alfa receives FDA breakthrough therapy designation
Read More
Santen launches Alesion ophthalmic solution in Japan
Read More
FDA grants priority review status to NDA for corneal cross-linking system
Read More
Celgene receives positive CHMP opinion for Abraxane in combination with gemcitabine
Read More
Cubist reports topline results from pivotal trial of ceftolozane/tazobactam in cUTIs
Read More
FDA grants fast track designation to Cerecor's CERC-301 for major depressive disorder
Read More
Anafranil approved for new indication in Japan
Read More
Preclinical findings suggest diminished abuse potential for MG-01CI
Read More
